How Much Does Spironolactone Cost in Maine in 2026?

Cash-Pay Pricing Across Maine Pharmacies

The average cash-pay price for generic spironolactone at Maine retail pharmacies in 2026 sits around $15 per month for a 30-day supply of 25 mg, 50 mg, or 100 mg tablets. This is one of the lowest out-of-pocket costs among commonly prescribed dermatologic medications, making it accessible even for uninsured patients.

That $15 figure represents the discounted generic price. The Pfizer-listed price for brand-name Aldactone remains approximately $80 per month, though very few pharmacies dispense the brand when generics are available 1. Prices at Maine chains like Hannaford, Walgreens, and Rite Aid cluster within a few dollars of one another for generics, but independent pharmacies in rural counties (Aroostook, Piscataquis, Washington) sometimes charge marginally more due to lower dispensing volume. Discount platforms like GoodRx, RxSaver, and SingleCare frequently bring the cash price below $10 at participating locations.

For context, a 2022 cost-effectiveness analysis published in JAMA Dermatology found that spironolactone at typical U.S. generic pricing produced higher quality-adjusted life years per dollar spent than isotretinoin for moderate hormonal acne in adult women 2. Price stability for this generic has held since at least 2019, and no supply disruptions affecting Maine were reported by the FDA Drug Shortage Database as of May 2026.

Maine Medicaid Coverage and Prior Authorization

Maine Medicaid (MaineCare) covers spironolactone, but requires prior authorization (PA) for most indications. PA approval typically takes 24 to 72 hours when the prescriber submits documentation of the clinical indication and any required step-therapy history.

For acne specifically, MaineCare reviewers generally expect documentation that the patient has tried and failed at least one topical retinoid and one oral antibiotic before approving spironolactone. This step-therapy requirement aligns with prescribing patterns recommended in the American Academy of Dermatology's 2024 acne guidelines 3. Once approved, the PA is valid for 12 months and renewable. Copays under MaineCare for preferred generics are typically $1 to $3.

A retrospective analysis of Medicaid claims data published in the Journal of the American Academy of Dermatology found that spironolactone prescriptions for acne among women aged 18 to 45 increased 147% between 2015 and 2021 across all state Medicaid programs 4. Maine's PA requirement has not prevented this growth locally. Prescribers who submit PA requests through the electronic prior authorization (ePA) portal report faster turnaround than faxed forms.

For patients with both MaineCare and Medicare (dual-eligible), Medicare Part D typically serves as the primary payer. Spironolactone appears on most Part D formularies without PA for its FDA-approved cardiovascular indications 5.

Commercial Insurance Coverage in Maine

Most commercial insurers operating in Maine place generic spironolactone on Tier 1 or Tier 2 of their formularies. This means copays between $5 and $20 per month depending on the plan. Major carriers in the state include Anthem Blue Cross Blue Shield, Aetna, Cigna, Harvard Pilgrim, and Community Health Options.

Plans sold through the ACA marketplace (CoverME.gov) must cover prescription drugs as an essential health benefit. Generic spironolactone falls under this mandate. Patients purchasing marketplace plans should verify whether their specific formulary requires PA for dermatologic use. Some plans restrict PA-free access to cardiovascular indications only.

Employer-sponsored plans in Maine follow similar patterns. A 2023 analysis of commercial claims found that among women prescribed spironolactone for acne, 89% had the medication covered with a median copay of $10 6. Self-insured employer plans (governed by ERISA rather than state insurance law) may have different formulary rules, so checking the plan's specific drug list remains necessary.

The Endocrine Society's 2023 clinical practice guideline on the evaluation and treatment of hirsutism recommends spironolactone as first-line pharmacotherapy for hirsutism in premenopausal women 7. Citing this guideline in PA requests for off-label dermatologic use can strengthen the clinical rationale and improve approval rates.

Compounded Spironolactone in Maine

Compounded spironolactone is legal in Maine through 503A pharmacies. These are state-licensed compounding pharmacies that prepare individualized prescriptions based on a valid patient-prescriber relationship.

Topical spironolactone (typically 2% to 5% cream or gel) is the most common compounded formulation prescribed for acne. A randomized controlled trial published in the Journal of Drugs in Dermatology demonstrated that topical 5% spironolactone gel reduced inflammatory lesion counts by 50% at 12 weeks compared to 25% with vehicle 8. Topical formulations aim to deliver anti-androgenic effects locally while minimizing systemic side effects such as hyperkalemia and menstrual irregularities.

Pricing for compounded formulations varies widely. Some 503A pharmacies in Maine offer compounded spironolactone creams for $30 to $60 per month, though pricing depends on the base, concentration, and quantity. Insurance rarely covers compounded medications, so patients should expect to pay out of pocket. A few Maine compounding pharmacies, including those in Portland and Bangor, have reported increased demand for topical spironolactone since 2024.

503B outsourcing facilities (which compound without individual prescriptions) operate under FDA oversight and can ship to Maine. However, most dermatologic spironolactone compounding occurs through 503A pharmacies with a patient-specific prescription 9.

Telehealth Access to Spironolactone in Maine

Maine permits telehealth prescribing of spironolactone without restrictions. The state's telehealth parity law requires insurers to cover telehealth visits at the same rate as in-person appointments, and prescribers licensed in Maine (or holding an interstate compact license) can prescribe spironolactone after a synchronous video or audio evaluation.

Multiple national telehealth platforms serve Maine patients for acne treatment, including Dermatologist On Call, Apostrophe, and Curology. HealthRX also offers telehealth consultations for spironolactone in Maine. Telehealth visits typically cost $50 to $150 without insurance, with many platforms offering subscription models that bundle the consultation and medication.

A 2021 study in Telemedicine and e-Health found that teledermatology visits for acne resulted in equivalent clinical outcomes to in-person visits at 12 weeks, with higher patient satisfaction scores related to convenience 10. For Maine residents in rural counties where dermatologists are scarce (only 3.2 dermatologists per 100,000 residents statewide according to the AAD workforce study), telehealth meaningfully expands access to spironolactone prescribing 11.

Prescribers conducting telehealth visits for spironolactone should still order baseline potassium and renal function labs, per the FDA prescribing information [1]. Most telehealth platforms direct patients to local labs (Quest, LabCorp, or hospital outpatient labs) for these draws. Maine has Quest Diagnostics locations in Portland, South Portland, and Scarborough, with LabCorp available in several additional cities.

Clinical Evidence for Spironolactone in Acne

Spironolactone is not FDA-approved for acne. Its use in hormonal acne is off-label but supported by substantial evidence and guideline endorsement.

The largest retrospective study, by Layton et al. in the British Journal of Dermatology (2017), analyzed outcomes in over 900 women treated with spironolactone for acne and found that 66% achieved clear or almost-clear skin at doses of 50 to 150 mg daily, with a median response time of 3 months 12. More recently, a systematic review and meta-analysis in the Journal of the American Academy of Dermatology pooling 18 studies (N=3,500+) confirmed significant reductions in both inflammatory and non-inflammatory lesion counts with spironolactone compared to placebo and active comparators 13.

The FASCE trial (2024), a double-blind RCT published in the BMJ, randomized 410 women with moderate-to-severe acne to spironolactone 50 mg vs. placebo over 24 weeks. The spironolactone group showed a 37% greater reduction in Investigator Global Assessment scores (P<0.001) and a 42% reduction in inflammatory lesion counts versus 19% with placebo 14.

Dr. Kanade Shinkai, professor of dermatology at UCSF, noted in a 2023 editorial: "Spironolactone has become the de facto first-line systemic therapy for adult female acne in clinical practice, even as we await more phase III data to support formal regulatory approval" 15.

Safety Monitoring and Potassium Considerations

The primary safety concern with spironolactone is hyperkalemia. The FDA label recommends checking serum potassium within one week of initiation or dose increase, especially in patients with renal impairment or those taking other potassium-sparing medications 1.

In practice, the risk is low in young, healthy women. A large retrospective cohort study published in JAMA Dermatology (2015) examined 1,802 healthy women aged 18 to 45 taking spironolactone for acne and found zero cases of clinically significant hyperkalemia (K+ >6.0 mEq/L), leading the authors to question whether routine monitoring is necessary in this population 16. The AAD guidelines acknowledge this data but still recommend at least a baseline potassium check.

Other common side effects include menstrual irregularities (reported in up to 30% of patients at doses above 100 mg), breast tenderness, and dizziness. A Cochrane systematic review of spironolactone for hirsutism and acne found that most side effects are dose-dependent and resolve with dose reduction 17. Spironolactone is FDA Pregnancy Category X and must not be prescribed to patients who are or may become pregnant, due to anti-androgenic effects on fetal development.

Manufacturer Savings Programs and Discount Cards

Pfizer offers a savings card for brand-name Aldactone, though its utility is limited given that generic prices already fall well below brand pricing. The savings card may reduce brand copays to $0 to $15 for commercially insured patients, but it does not apply to government-funded insurance (Medicaid, Medicare, Tricare).

For generic spironolactone, the most practical savings tools in Maine are pharmacy discount cards: GoodRx, SingleCare, and RxAssist. These programs are accepted at most Maine chain and independent pharmacies and can bring cash prices to $4 to $9 for a 30-day supply at select locations. Patients should compare prices across nearby pharmacies, as GoodRx pricing varies by location even within the same city.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) ships to Maine and lists spironolactone at manufacturer cost plus a flat 15% margin and $5 dispensing fee, often totaling $5 to $8 per month. This mail-order option suits patients comfortable waiting 3 to 5 business days for delivery 18.

Some Maine community health centers and federally qualified health centers (FQHCs) participate in the 340B Drug Pricing Program, which can provide spironolactone at substantially reduced prices. The Health Resources and Services Administration (HRSA) lists participating 340B entities by state 19.